Biotechnology
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson on Tuesday sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act. The lawsuit filed in federal district court in New Jersey argues the Medicare negotiations violate […]
Read More
Novartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buyback
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Bloomberg | Bloomberg | Getty Images Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance on strong drug sales and announced a $15 billion share buyback. The company […]
Read More
Nearly 3 million people cut from Medicaid coverage even though many might still be eligible
Supporters hold up Save Medicaid signs during the Senate Democrats’ news conference at the Capitol with disability advocates to oppose the Republicans’ Graham-Cassidy health care bill. Bill Clark | CQ-Roll Call, Inc. | Getty Images Nearly 3 million people have been kicked off Medicaid since Covid-19 pandemic protections expired in April, with three-quarters of those […]
Read More
Fda approves AstraZeneca, Sanofi shot that shields infants and toddlers versus RSV
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Visuals The Meals and Drug Administration on Monday accredited AstraZeneca and Sanofi‘s shot that guards infants and toddlers versus respiratory syncytial virus, which is the leading trigger of hospitalization between infants in the U.S. Nirsevimab is the initial shot authorised by the […]
Read More
Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer’s treatment, donanemab, and expects the agency to make a decision by the end of the year. Eli Lilly is […]
Read More
Insurance may not cover birth control drug Opill without prescription
A package of the daily contraceptive Opill is seen in an undated illustration. Perrigo | via Reuters The first birth control pill sold without a prescription in the U.S. could remain out of reach for some women and girls because health insurance plans are not required to cover the medication in its over-the-counter form. The […]
Read More
UnitedHealth stock jumps after earnings top estimates despite rising medical costs
Representatives speak with customers at a UnitedHealthcare store in Queens, New York. Michael Nagle | Bloomberg | Getty Images UnitedHealth Group’s stock price jumped Friday after the health-care conglomerate reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations despite rising medical costs. The results eased investor concerns after the Minnesota-based company flagged a […]
Read More
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Friday said it will acquire Versanis, a privately held obesity drug maker, for up to $1.93 billion to boost the pharmaceutical giant’s weight loss treatment portfolio. Eli Lilly agreed to pay Versanis shareholders in […]
Read More
FDA says soda sweetener aspartame is safe, disagreeing with WHO finding on possible cancer link
Cans of PepsiCo’s Pepsi Zero Sugar soda are displayed for an arranged photograph taken in Tiskilwa, Illinois, on Wednesday, April 17, 2019. Daniel Acker | Bloomberg | Getty Images The U.S. Food and Drug Administration disagrees with a World Health Organization finding that the widely used soda sweetener aspartame possibly causes cancer in humans, saying […]
Read More
WHO says soda sweetener aspartame may cause cancer, but it’s safe within limits
A can of Diet Coke in a supermarket, as an artificial sweetener commonly used in thousands of products including diet fizzy drinks, ice cream and chewing gum is to be listed as posing a possible cancer risk to humans, according to reports. Yui Mok | Pa Images | Getty Images The World Health Organization on […]
Read More